Gentian Diagnostics ASA (OSL:GENT)
Norway
· Delayed Price · Currency is NOK 55.00
-2.00 (-3.51%)
May 9, 2025, 4:26 PM CET
Gentian Diagnostics ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 158.07 | 152.07 | 135.15 | 101.64 | 83.12 | 63.33 | Upgrade
|
| Other Revenue | - | - | - | 10.29 | 16.89 | 15.55 | Upgrade
|
| Revenue | 158.07 | 152.07 | 135.15 | 111.92 | 100.01 | 78.88 | Upgrade
|
| Revenue Growth (YoY) | 11.14% | 12.52% | 20.76% | 11.91% | 26.78% | 42.43% | Upgrade
|
| Cost of Revenue | 67.2 | 69.25 | 70.91 | 52.64 | 43.18 | 32.59 | Upgrade
|
| Gross Profit | 90.86 | 82.82 | 64.25 | 59.29 | 56.83 | 46.3 | Upgrade
|
| Selling, General & Admin | 49.83 | 49.78 | 48.12 | 37.42 | 34.35 | 31.32 | Upgrade
|
| Research & Development | 20.91 | 21.92 | 36.08 | - | - | - | Upgrade
|
| Other Operating Expenses | -4.72 | -4.6 | -7.19 | 34.86 | 37.98 | 26.17 | Upgrade
|
| Operating Expenses | 66.02 | 67.09 | 77.01 | 82.52 | 79.68 | 64.12 | Upgrade
|
| Operating Income | 24.85 | 15.72 | -12.76 | -23.23 | -22.85 | -17.82 | Upgrade
|
| Interest Expense | -3.23 | -0.66 | -0.8 | -1.26 | -1.38 | - | Upgrade
|
| Interest & Investment Income | 3.59 | 3.59 | 2.67 | 1.11 | 0.09 | 0.6 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.5 | 1.5 | 0.6 | -0.2 | -0.6 | 0.29 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.7 | -0.08 | -0.08 | -0.05 | -0.06 | -0.54 | Upgrade
|
| EBT Excluding Unusual Items | 25.99 | 20.06 | -10.37 | -23.62 | -24.79 | -17.47 | Upgrade
|
| Pretax Income | 25.99 | 20.06 | -10.37 | -23.62 | -24.79 | -17.47 | Upgrade
|
| Income Tax Expense | -22.9 | -25.23 | 0.28 | - | - | - | Upgrade
|
| Net Income | 48.89 | 45.29 | -10.65 | -23.62 | -24.79 | -17.47 | Upgrade
|
| Net Income to Common | 48.89 | 45.29 | -10.65 | -23.62 | -24.79 | -17.47 | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 16 | 16 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 2.93% | 2.21% | - | 0.04% | 0.07% | 0.01% | Upgrade
|
| EPS (Basic) | 3.16 | 2.94 | -0.69 | -1.53 | -1.61 | -1.13 | Upgrade
|
| EPS (Diluted) | 3.08 | 2.87 | -0.69 | -1.53 | -1.61 | -1.13 | Upgrade
|
| Free Cash Flow | 16.79 | 12.08 | 14.5 | -22.59 | -28.08 | -15.24 | Upgrade
|
| Free Cash Flow Per Share | 1.06 | 0.77 | 0.94 | -1.47 | -1.82 | -0.99 | Upgrade
|
| Dividend Per Share | 0.400 | 0.400 | - | - | - | - | Upgrade
|
| Gross Margin | 57.48% | 54.46% | 47.54% | 52.97% | 56.83% | 58.69% | Upgrade
|
| Operating Margin | 15.72% | 10.34% | -9.44% | -20.76% | -22.84% | -22.60% | Upgrade
|
| Profit Margin | 30.93% | 29.79% | -7.88% | -21.10% | -24.79% | -22.15% | Upgrade
|
| Free Cash Flow Margin | 10.62% | 7.94% | 10.73% | -20.18% | -28.07% | -19.32% | Upgrade
|
| EBITDA | 27.76 | 18.6 | -9.9 | -20.49 | -21.32 | -16.11 | Upgrade
|
| EBITDA Margin | 17.56% | 12.23% | -7.32% | -18.30% | -21.32% | -20.42% | Upgrade
|
| D&A For EBITDA | 2.91 | 2.88 | 2.87 | 2.75 | 1.53 | 1.71 | Upgrade
|
| EBIT | 24.85 | 15.72 | -12.76 | -23.23 | -22.85 | -17.82 | Upgrade
|
| EBIT Margin | 15.72% | 10.34% | -9.44% | -20.76% | -22.84% | -22.60% | Upgrade
|
| Revenue as Reported | - | - | - | 111.92 | 100.01 | 78.88 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.